Cat. No. 0609
Biological ActivityIntermediate in mitochondrial fatty acid oxidation. Has a wide range of biological actions including the inhibition of protein kinase C and cell membrane disruption.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Requero et al (1995) The membrane-perturbing properties of palmitoyl-coenzyme A and palmitoylcarnitine. A comparative study. Biochemistry 34 10400. PMID: 7654694.
Criddle et al (1990) The effects of novel vasodilator long chain acyl carnitine esters in the isolated perfused heart of the rat. Br.J.Pharmacol. 99 477. PMID: 1691947.
Dainty et al (1990) Interactions of palmitoyl carnitine with the endothelium in rat aorta. Br.J.Pharmacol. 100 241. PMID: 1696151.
Nakadate and Blumberg (1987) Modulation by palmitoylcarnitine of protein kinase C activation. Cancer Res. 47 6537. PMID: 3479247.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses (±)-Palmitoylcarnitine chloride from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: (±)-Palmitoylcarnitine chloride, supplier, Protein, kinase, C, inhibitors, inhibits, PKC, Kinases, fatty, acid, oxidation, Tocris Bioscience, Other Lipid Metabolism products